Literature DB >> 12629211

Enhanced insulin sensitivity in mice lacking ganglioside GM3.

Tadashi Yamashita1, Akira Hashiramoto, Martin Haluzik, Hiroki Mizukami, Shoshannah Beck, Aaron Norton, Mari Kono, Shuichi Tsuji, Jose Luis Daniotti, Norbert Werth, Roger Sandhoff, Konrad Sandhoff, Richard L Proia.   

Abstract

Gangliosides are sialic acid-containing glycosphingolipids that are present on all mammalian plasma membranes where they participate in recognition and signaling activities. We have established mutant mice that lack GM3 synthase (CMP-NeuAc:lactosylceramide alpha2,3-sialyltransferase; EC 2.4.99.-). These mutant mice were unable to synthesize GM3 ganglioside, a simple and widely distributed glycosphingolipid. The mutant mice were viable and appeared without major abnormalities but showed a heightened sensitivity to insulin. A basis for the increased insulin sensitivity in the mutant mice was found to be enhanced insulin receptor phosphorylation in skeletal muscle. Importantly, the mutant mice were protected from high-fat diet-induced insulin resistance. Our results show that GM3 ganglioside is a negative regulator of insulin signaling, making it a potential therapeutic target in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629211      PMCID: PMC152312          DOI: 10.1073/pnas.0635898100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

Authors:  A R Saltiel
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  The glycosynapse.

Authors:  Sen-itiroh Hakomori Si
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

3.  Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae.

Authors:  Saara Vainio; Sanna Heino; Jan-Eric Mansson; Pam Fredman; Esa Kuismanen; Outi Vaarala; Elina Ikonen
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

Review 4.  Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.

Authors:  D E Moller
Journal:  Trends Endocrinol Metab       Date:  2000-08       Impact factor: 12.015

Review 5.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

6.  Insulin signalling and the regulation of glucose and lipid metabolism.

Authors:  A R Saltiel; C R Kahn
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 7.  Traveling for the glycosphingolipid path.

Authors:  S Hakomori
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

8.  Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle.

Authors:  J K Kim; M D Michael; S F Previs; O D Peroni; F Mauvais-Jarvis; S Neschen; B B Kahn; C R Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

9.  Ganglioside GM3 participates in the pathological conditions of insulin resistance.

Authors:  Seiichi Tagami; Jin-ichi Inokuchi Ji; Kazuya Kabayama; Haruhiko Yoshimura; Futoshi Kitamura; Satoshi Uemura; Chie Ogawa; Atsushi Ishii; Masaki Saito; Yoshinori Ohtsuka; Shinji Sakaue; Yasuyuki Igarashi
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

10.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder.

Authors:  Y Liu; R Wada; H Kawai; K Sango; C Deng; T Tai; M P McDonald; K Araujo; J N Crawley; U Bierfreund; K Sandhoff; K Suzuki; R L Proia
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

View more
  178 in total

1.  Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.

Authors:  Keiji Nakamura; Tomoko Kohda; Yuto Shibata; Kentaro Tsukamoto; Hideyuki Arimitsu; Mitsunori Hayashi; Masafumi Mukamoto; Nobuyuki Sasakawa; Shunji Kozaki
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 3.  Spatial organization of transmembrane receptor signalling.

Authors:  Ioanna Bethani; Sigrid S Skånland; Ivan Dikic; Amparo Acker-Palmer
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

4.  Expression machinery of GM4: the excess amounts of GM3/GM4S synthase (ST3GAL5) are necessary for GM4 synthesis in mammalian cells.

Authors:  Satoshi Uemura; Shinji Go; Fumi Shishido; Jin-ichi Inokuchi
Journal:  Glycoconj J       Date:  2013-09-03       Impact factor: 2.916

5.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

6.  Gangliosides trigger inflammatory responses via TLR4 in brain glia.

Authors:  Ilo Jou; Jee Hoon Lee; Soo Young Park; Hee Jung Yoon; Eun-Hye Joe; Eun Jung Park
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Ceramides and glucosylceramides are independent antagonists of insulin signaling.

Authors:  Jose A Chavez; M Mobin Siddique; Siew Tein Wang; Jianhong Ching; James A Shayman; Scott A Summers
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

Review 8.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

9.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

10.  Stimulation of GLUT4 (glucose transporter isoform 4) storage vesicle formation by sphingolipid depletion.

Authors:  Zhi-Jie Cheng; Raman Deep Singh; Teng-Ke Wang; Eileen L Holicky; Christine L Wheatley; David A Bernlohr; David L Marks; Richard E Pagano
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.